Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other financing activities (2016 - 2018)

Arcadia Biosciences filings provide 4 years of Other financing activities readings, the most recent being $3000.0 for Q3 2018.

  • On a quarterly basis, Other financing activities changed N/A to $3000.0 in Q3 2018 year-over-year; TTM through Dec 2018 was $1.3 million, a N/A change, with the full-year FY2018 number at $1.3 million, changed N/A from a year prior.
  • Other financing activities hit $3000.0 in Q3 2018 for Arcadia Biosciences, down from $373000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.6 million in Q4 2014 to a low of -$948000.0 in Q2 2015.
  • Median Other financing activities over the past 4 years was $106000.0 (2015), compared with a mean of $370555.6.
  • The widest YoY moves for Other financing activities: up 100.11% in 2016, down 96.37% in 2016.
  • Arcadia Biosciences' Other financing activities stood at $1.6 million in 2014, then plummeted by 93.31% to $106000.0 in 2015, then crashed by 99.06% to $1000.0 in 2016, then skyrocketed by 200.0% to $3000.0 in 2018.
  • The last three reported values for Other financing activities were $3000.0 (Q3 2018), $373000.0 (Q2 2018), and $932000.0 (Q1 2018) per Business Quant data.